phish said:You cant deny the fact that sintov in his study regrew a ton of hair with a lot smaller doses then prostrate cancer patients use...
phish said:Some say sintov didnt prove that the gel stoped system absorption, but i will believe sintov because he is a very knowledgeable and good guy in the hair world. If in fact after a month I get a blood test and its vastly differently then before i started then I will agree sintovs study was flawed and didn't prove the gel didn't stop system absorption.
philly said:"Flutamide must be systemically metabolised before it becomes the strong hydroxyflutamide which blocks androgen receptors."
Not true. ?-hydroxylation takes place in the skin.
docj077 said:philly said:"Flutamide must be systemically metabolised before it becomes the strong hydroxyflutamide which blocks androgen receptors."
Not true. ?-hydroxylation takes place in the skin.
How is it safe then? If the hydroxylation takes place there, then the formation of the hepatotoxic metabolites would also occur. Both CYP1A2 and CYP1B1 are present in human skin, which means you'll not only get the metabolite that we want, but also the metabolite that does the most damage. That combined with possible system side effects secondary to ANY absorption at all is a recipe for disaster.
The authors of the article also mention the possibility that the difference between good responsers and poor responsers to minoxidil may be due to a difference in their sulfotransferases metabolism in the skin. Since minoxidil sulphate is already sulphated its action does no longer depend on the sulfotransferases, therefore poor minoxidil responsers may become good responders with minoxidil sulphate.